CBDCA + Pemetrexed + Bevacizumab and Its Maintenance Chemotherapy in a Case of Solitary Breast Metastasis from a Lung Adenocarcinoma Resistant to Gefitinib

Based on the AVAPERL trial (36th ESMO 2011), CBDCA + pemetrexed + bevacizumab and its maintenance chemotherapy with pemetrexed + bevacizumab is a new promising regimen for the treatment of advanced non-small-cell lung adenocarcinoma. Herein, we report the rare case of a patient with solitary breast...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sato, Kazuhide, Takeyama, Yoshihiro, Yoshihara, Motoi, Kato, Toshio, Hashimoto, Hiroyuki, Fukui, Yasutaka, Gonda, Hideo, Suzuki, Ryujiro
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2012
Matèries:
October, 2012
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3492973/
https://ncbi.nlm.nih.gov/pubmed/23139670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000343678
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars